Cascinu, Stefano <br/><br/>
Sorafenib does not improve efficacy of chemotherapy in advanced pancreatic cancer: A GISCAD randomized phase II study.  [electronic resource] 

 -  Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver  Feb 2014 
 - 182-6 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1878-3562 
<br/><br/><label>Standard No.: </label>10.1016/j.dld.2013.09.020  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--drug therapy<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Cisplatin--administration & dosage<br/>Deoxycytidine--administration & dosage<br/>Disease-Free Survival<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Niacinamide--administration & dosage<br/>Pancreatic Neoplasms--drug therapy<br/>Phenylurea Compounds--administration & dosage<br/>Sorafenib<br/>Treatment Outcome<br/>Gemcitabine